LYSAKARE

This brand name is authorized in Austria, Estonia, France, Hong Kong, Ireland, Japan, Lithuania, Poland, United Kingdom

Active ingredients

The drug LYSAKARE contains a combination of these active pharmaceutical ingredients (APIs):

1 Arginine
UNII F7LTH1E20Y - ARGININE HYDROCHLORIDE

Arginine is an essential amino acid that is physiologically active in the L-form. It is commonly found as a component of total parenteral nutrition.

Read about Arginine
2 Lysine
UNII JNJ23Q2COM - LYSINE HYDROCHLORIDE
Read about Lysine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LYSAKARE Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AF11 V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1800032
Country: FR Base de données publique des médicaments Identifier(s): 65395602
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 386102
Country: HK Department of Health Drug Office Identifier(s): 66931
Country: JP 医薬品医療機器総合機構 Identifier(s): 3253416A1020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1088319
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100424790

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.